Back
Xeris Biopharma Holdings Vs. Adial Pharmaceuticals Industry Stock Comparison
Buy
89
XERS
Xeris Biopharma Holdings
Last Price:
2.03
Seasonality Move:
-12.45%
Sell
14
ADIL
Adial Pharmaceuticals
Last Price:
1.40
Seasonality Move:
-13.09%
Buy
89
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $1.98. The Score for XERS is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
14
Adial Pharmaceuticals (ADIL)
is a Sell
Is Adial Pharmaceuticals a Buy, Sell or Hold?
- The current Adial Pharmaceuticals [ADIL] share price is $1.42. The Score for ADIL is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ADIL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $1.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
ADIL Stock Price Chart
What is Adial Pharmaceuticals's stock price today?
-
The Adial Pharmaceuticals share price today is $1.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADIL is experiencing slight buying pressure.
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 56.2 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 1.91) | Buy |
| Bollinger Bands (100): | (1.89 - 2.77) | Sell |
ADIL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 41.2 | Sell |
| Chaikin Money Flow: | 40773 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.46 - 2.22) | Sell |
| Bollinger Bands (100): | (1.13 - 2.05) | Sell |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 1.81 | Buy |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2.15 | Sell |
| 8-day EMA: | 1.88 | Buy |
| 20-day EMA: | 1.87 | Buy |
| 50-day EMA: | 2.02 | Sell |
| 200-day EMA: | 2.16 | Sell |
ADIL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.52 | Sell |
| 20-day SMA: | 1.68 | Sell |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 2.24 | Sell |
| 8-day EMA: | 1.52 | Sell |
| 20-day EMA: | 1.64 | Sell |
| 50-day EMA: | 1.68 | Sell |
| 200-day EMA: | 3.13 | Sell |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.
Adial Pharmaceuticals Earnings Growth & ADIL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.07 per share, an increase this year of $2.43 per share, and an increase next year of $0.42 per share.
Xeris Biopharma Holdings Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adial Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||